144 related articles for article (PubMed ID: 11422245)
1. In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Carricajo A; Vermesch R; Aubert G
Clin Microbiol Infect; 2001 Apr; 7(4):218-26. PubMed ID: 11422245
[No Abstract] [Full Text] [Related]
2. In vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative Staphylococcus.
Raymond J; Vedel G; Bergeret M
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):481-3. PubMed ID: 9635241
[No Abstract] [Full Text] [Related]
3. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Raymond J; Vedel G; Bergeret M
J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Lee DG; Chun HS; Yim DS; Choi SM; Choi JH; Yoo JH; Shin WS; Kang MW
Antimicrob Agents Chemother; 2003 Dec; 47(12):3768-73. PubMed ID: 14638480
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
7. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Bergeret M; Raymond J
J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
[TBL] [Abstract][Full Text] [Related]
8. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
9. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
[TBL] [Abstract][Full Text] [Related]
10. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
13. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Tsuji BT; Rybak MJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1997 Nov; 41(11):2497-501. PubMed ID: 9371356
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin].
Yourassowsky E; Schoutens E
Acta Clin Belg; 1971; 26(3):139-45. PubMed ID: 5211728
[No Abstract] [Full Text] [Related]
16. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
[No Abstract] [Full Text] [Related]
17. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
Gomes DM; Ward KE; LaPlante KL
Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
[TBL] [Abstract][Full Text] [Related]
18. In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Valdes JM; Baltch AL; Smith RP; Ritz WJ
J Antimicrob Chemother; 1990 Dec; 26(6):855-7. PubMed ID: 2081726
[No Abstract] [Full Text] [Related]
19. Evaluation of the effect of serum proteins on the antibacterial activity and pharmacodynamics of ceftaroline against Staphylococcus aureus.
Dalhoff A; Schubert S
Int J Antimicrob Agents; 2013 Sep; 42(3):285-7. PubMed ID: 23891526
[No Abstract] [Full Text] [Related]
20. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
